United States· US:68382-184_a0d3beee-e225-4437-9b64-9da3973a8735
Glipizide and Metformin Hydrochloride
A medicinal product containing glipizide; metformin hydrochloride, registered in United States by Zydus Pharmaceuticals USA Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GLIPIZIDE; METFORMIN HYDROCHLORIDE
- Manufacturer
- Zydus Pharmaceuticals USA Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 26, 2026
Packs & prices · 4
- ndc1168382-184-01
- ndc1168382-184-10
- ndc1168382-184-16
- ndc1168382-184-77
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfad39a0-ddde-41d6-8f80-92ac4f939c20 GET /v1/drugs/dfad39a0-ddde-41d6-8f80-92ac4f939c20?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2.5; 250",
"substance": "GLIPIZIDE; METFORMIN HYDROCHLORIDE",
"productndc": "68382-184",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA078905",
"marketing_category": "ANDA"
}See everything about glipizide; metformin hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.